SOT102
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SOT102, covering 2025-11-17 to 2025-11-17. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of SOT102 Antibody Drug Conjugate in Patients With Advanced Gastric and Pancreatic Adenocarcinoma [Phase 1, Phase 2]